Corrigendum to “Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways” [Int. Immunopharmacol. 55 (2018) 9–19]

Autor: Li, Jushuang, Bao, Liping, Zha, Dongqing, Zhang, Lian, Gao, Ping, Zhang, Juan, Wu, Xiaoyan
Zdroj: In International Immunopharmacology 5 January 2024 126
Databáze: ScienceDirect